search icon
  • Print
  • ShareThis
  • Text Size
  • Other Policy Issues

    Learn more about HIVMA's efforts on other policy issues.

  • Search More Comments

    HIVMA Comments for Senate HELP Committee Hearing on Drug Pricing

    On behalf of the HIV Medicine Association, thank you for holding the full committee hearing on “The Cost of Prescription Drugs: An Examination of The National Academies of Sciences, Engineering, and Medicine Report Making Medicines Affordable: A National Imperative.” HIVMA represents more than 5,000 physicians, researchers and other healthcare professionals working on the frontlines of the HIV epidemic in communities across the country. 


    HIVMA Testimony for Senate HELP Committee Hearing on Drug Pricing  PDF 


    HIVMA and medical professional societies thank Congress for the H.R. 698/S. 330, the “HIV Organ Policy Equity” (HOPE) Act

    HIVMA joined a letter with 10 other medical professional societies thanking both Chambers of Congress for working together to finalize passage of bi-partisan, life-saving, and cost effective legislation H.R. 698/S. 330, the “HIV Organ Policy Equity” (HOPE) Act. The letter notes that more than 8,000 people die each year waiting for a suitable organ to become available while, at the same time, the national waiting list for donor organs continues to grow.

    HIVMA comments in support of UNOS’ proposed amendments to Organ Procurement and Transplantation Network (OPTN)

    In another step forward for implementation of the HOPE Act, HIVMA commented in support of proposed revisions to OPTN regulations that will enable transplant centers to participate in studies to evaluate organ transplantation between HIV-infected donors and recipients with HIV. The letter notes that the proposed criteria for evaluating organ transplants between HIV-infected individuals appear reasonable and appropriate to monitor progress and potential challenges.

    HIVMA Comments on NIH’s Proposed Safeguards and Research Criteria for Implementation of the HIV Organ Policy Equity (HOPE) Act

    HIVMA commented on the NIH’s proposed research criteria for the clinical study of organ transplants between HIV-infected donors and recipients.  The letter notes that enactment and implementation of the HOPE Act has been a high priority policy issue for HIVMA from the earliest stages of the policy reform process. It expresses HIVMA’s appreciation of the opportunity to provide stakeholder input on development of the HOPE Act research criteria on several occasions leading up to the current proposal. We commend the proposal as generally sound.

    HIVMA Comments on LGBT Research Committee Report

    HIVMA weighed in with public comments on the NIH’s proposed strategic plan for a trans-NIG research agenda on identifying and addressing the health needs of the LGBT population.

    HIVMA Comments on USPSTF HIV Screening

    In a letter to the U.S. Preventive Services Task Force (USPSTF), HIVMA applauded the panel’s draft updated “Grade A” recommendation that clinicians screen everyone between the ages of 15 and 65, all pregnant women, and younger adolescents and older adults who are at higher risk for HIV infection. HIVMA’s comments note that if adopted and effectively implemented, this move will represent a monumental step forward in identifying the nearly 20 percent of individuals infected with HIV in this country that are undiagnosed and connecting them with lifesaving HIV care and treatment.



    HIVMA’s Public Comments on the National Quality Forum’s NQF’s Draft 2012 ID Measures Report

    HIVMA Board of Directors Chair Michael Horberg, MD, MAS, FIDSA, submitted public comments on behalf of HIVMA on the National Quality Forum’s (NQF’s) Draft Report on “Infectious Disease Consensus Standards Endorsement Maintenance 2012.” HIVMA’s comments urge NQF to play an active role in ensuring that the final endorsed HIV and related clinical quality measures are harmonized and streamlined across federal government agencies and programs, as well as between public and private payors and practice settings.

    HIV Infected Organ Donation

    Federal Law Should Allow Clinical Research on the Safety and Effectiveness of HIV-Infected‐to‐HIV‐Infected Organ Transplantation:  A change in policy is necessary to support medical progress and allow for research to fully evaluate HIV-infected organ donation to HIV‐infected patients.

    Comments on Medication Adherence in Adults with Chronic Conditions

    HIVMA weighed in on the Department of Health and Human Services’ (HHS’s) April 5, 2012 “Request for Information on Prescription Medication Adherence” to share lessons learned from the field of  HIV medicine that can inform strategies to improve medication adherence in adults with chronic conditions.

    CMS Proposal to Improve Part D Drug Utilization Controls for Antiretrovirals

    HIVMA sent a letter (PDF) to the Center for Medicare and Medicaid Services (CMS) raising concerns about a proposal to implement beneficiary-level controls to prevent overutilization of antiretrovirals under Medicare Part D.

    HIVMA Common Rule Comments

    HIVMA Comments on Human Subjects Research Protections: Enhancing Protections for Research Subjects and Reducing Burden, Delay, and Ambiguity for Investigators (Docket ID Number HHS-OPHS-2011-0005)

    Policy Statement on HIV Infected Organ Transplantation

    Federal Law Should Allow Clinical Research on the Safety and Effectiveness of HIV-Infected‐to‐HIV‐Infected Organ Transplantation:  A change in policy is necessary to support medical progress and allow for research to fully evaluate HIV-infected organ donation to HIV‐infected patients.

    Joint Statement on Implementation of the Debt Ceiling Agreement

    HIV Medicine Association and the Ryan White Medical Providers Coalition released a joint statement urging members of Congress to consider the human impact of the funding and policy decisions that they will be making in the coming months.

    Expanding Patient Access to Non-Physician Medicaid Providers

    In a letter to Senator Daniel Inouye, HIVMA Board Chair Kathleen Squires, MD expressed HIVMA's support and endorsement of his bill, the "Medicaid Advanced Practice Nurses and Physician Assistants Access Act of 2011" (S.56).

| IDSA | Contact Us

© Copyright HIVMA 2018 HIV Medicine Association

Full Site Mobile Site